UNDERWRITING AGREEMENT between MODULAR MEDICAL, INC. and TITAN PARTNERS GROUP LLC, A DIVISION OF AMERICAN CAPITAL PARTNERS, LLC as Representative of the several Underwriters SHARES of Common Stock MODULAR MEDICAL, INC.Underwriting Agreement • February 16th, 2024 • Modular Medical, Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledFebruary 16th, 2024 Company Industry JurisdictionThe undersigned, Modular Medical, Inc., a company incorporated under the laws of Nevada (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of Modular Medical, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Titan Partners Group LLC, a division of American Capital Partners, LLC, is acting as representative of the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
SOLARJUICE CO., LTD. UNDERWRITING AGREEMENTUnderwriting Agreement • February 8th, 2024 • SolarJuice Co., Ltd. • Semiconductors & related devices • New York
Contract Type FiledFebruary 8th, 2024 Company Industry Jurisdiction
6,500,000 ORDINARY SHARES AND PRE-FUNDED WARRANTS SCISPARC LTD. UNDERWRITING AGREEMENTUnderwriting Agreement • August 14th, 2023 • SciSparc Ltd. • Pharmaceutical preparations • New York
Contract Type FiledAugust 14th, 2023 Company Industry JurisdictionThe undersigned, SciSparc Ltd., a company organized under the laws of Israel (collectively with its Subsidiaries (as defined below), if any, the “Company”), hereby confirms its agreement (this “Agreement”) with Aegis Capital Corp. (the “Underwriter”) on the terms and conditions set forth herein.
POLYPID LTD. UNDERWRITING AGREEMENTUnderwriting Agreement • March 31st, 2023 • PolyPid Ltd. • Surgical & medical instruments & apparatus • New York
Contract Type FiledMarch 31st, 2023 Company Industry JurisdictionThe undersigned, PolyPid Ltd., a company incorporated under the laws of Israel (collectively with its Subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being Subsidiaries or affiliates of PolyPid Ltd., the “Company”), hereby confirms its agreement (this “Agreement”) with Newbridge Securities Corporation (the “Underwriter” or “Newbridge”) on the terms and conditions set forth herein.
UNDERWRITING AGREEMENTUnderwriting Agreement • February 21st, 2023 • Volitionrx LTD • In vitro & in vivo diagnostic substances • New York
Contract Type FiledFebruary 21st, 2023 Company Industry JurisdictionThe undersigned, VolitionRx Limited, a company incorporated under the laws of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of VolitionRx Limited, the “Company”), hereby confirms its agreement (this “Agreement”) with Newbridge Securities Corporation (the “Underwriter” or “Newbridge”) on the terms and conditions set forth herein.
10,396,974 CLASS A ORDINARY SHARES 7,786,300 PRE-FUNDED Warrants TO PURCHASE 7,786,300 ORDINARY SHARES AND 18,183,274 Warrants of CN ENERGY GROUP. INC. UNDERWRITING AGREEMENTUnderwriting Agreement • February 1st, 2023 • Cn Energy Group. Inc. • Industrial organic chemicals • New York
Contract Type FiledFebruary 1st, 2023 Company Industry JurisdictionThe undersigned, CN Energy Group. Inc., a British Virgin Islands company (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of CN Energy Group. Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Aegis Capital Corp. is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
3,000,000 SHARES OF COMMON STOCK VOLITIONRX LIMITED UNDERWRITING AGREEMENTUnderwriting Agreement • August 2nd, 2022 • Volitionrx LTD • In vitro & in vivo diagnostic substances • New York
Contract Type FiledAugust 2nd, 2022 Company Industry JurisdictionThe undersigned, VolitionRx Limited, a company incorporated under the laws of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of VolitionRx Limited, the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Newbridge Securities Corporation is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
BIT ORIGIN LTD UNDERWRITING AGREEMENTUnderwriting Agreement • June 7th, 2022 • BIT ORIGIN LTD • Meat packing plants • New York
Contract Type FiledJune 7th, 2022 Company Industry JurisdictionThe undersigned, Bit Origin Ltd, formerly known as China Xiangtai Food Co., Ltd., a Cayman Islands company limited by shares (collectively with its Subsidiaries (as defined below) the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Univest Securities, LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
Hoth Therapeutics, Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • April 13th, 2022 • Hoth Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 13th, 2022 Company Industry JurisdictionThe undersigned, Hoth Therapeutics, Inc., a company incorporated under the laws of Nevada (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of Hoth Therapeutics, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which EF Hutton, division of Benchmark Investments, LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
UNDERWRITING AGREEMENTUnderwriting Agreement • March 23rd, 2022 • Imperial Petroleum Inc./Marshall Islands • Deep sea foreign transportation of freight • New York
Contract Type FiledMarch 23rd, 2022 Company Industry JurisdictionThe undersigned, Imperial Petroleum Inc., a company incorporated under the laws of the Republic of the Marshall Islands (collectively with its subsidiaries and controlled affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or controlled affiliates of Imperial Petroleum Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Maxim Group LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
UNDERWRITING AGREEMENTUnderwriting Agreement • March 16th, 2022 • Imperial Petroleum Inc./Marshall Islands • Deep sea foreign transportation of freight • New York
Contract Type FiledMarch 16th, 2022 Company Industry JurisdictionThe undersigned, Imperial Petroleum Inc., a company incorporated under the laws of the Republic of the Marshall Islands (collectively with its subsidiaries and controlled affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or controlled affiliates of Imperial Petroleum Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Maxim Group LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
3,813,560 AMERICAN DEPOSITARY SHARES EACH REPRESENTING 40 ORDINARY SHARES, NO PAR VALUE PER SHARE BIONDVAX PHARMACEUTICALS, LTD. UNDERWRITING AGREEMENTUnderwriting Agreement • December 29th, 2021 • BiondVax Pharmaceuticals Ltd. • Biological products, (no disgnostic substances) • New York
Contract Type FiledDecember 29th, 2021 Company Industry JurisdictionThe undersigned, BiondVax Pharmaceuticals, Ltd., a company incorporated under the laws of Israel (collectively with its Subsidiaries (as defined below), if any, the “Company”), hereby confirms its agreement (this “Agreement”) with Aegis Capital Corp. (the “Underwriter”) on the terms and conditions set forth herein. The Underlying Ordinary Shares (as defined below) are to be deposited pursuant to a deposit agreement, as amended, dated May 11, 2015 (the “Deposit Agreement”), among the Company, The Bank of New York Mellon, as depositary (the “Depositary”), and holders and beneficial holders from time to time of the ADRs (as defined below) issued by the Depositary and evidencing the ADSs (as defined below). Each ADS represents 40 Ordinary Shares (as defined below) deposited pursuant to the Deposit Agreement.
SHARES OF COMMON STOCK OF APPLIED UV, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • December 27th, 2021 • Applied UV, Inc. • Electric lighting & wiring equipment • New York
Contract Type FiledDecember 27th, 2021 Company Industry JurisdictionThe undersigned, Applied UV, Inc., a company incorporated under the laws of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of Applied UV, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which EF Hutton, division of Benchmark Investments, LLC. is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
TANTECH HOLDINGS LTD. UNDERWRITING AGREEMENTUnderwriting Agreement • December 7th, 2021 • Tantech Holdings LTD • Industrial organic chemicals • New York
Contract Type FiledDecember 7th, 2021 Company Industry JurisdictionThe undersigned, Tantech Holdings Ltd., a British Virgin Islands company limited by shares (collectively with its Subsidiaries (as defined below) the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Aegis Capital Corp. is acting as representative to the several Underwriters (the “Representative” or “Aegis”) and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
1,132,111 CLASS A ORDINARY SHARES IN THE FORM OF AMERICAN DEPOSITARY SHARES of ANPAC BIO-MEDICAL SCIENCE CO., LTD. UNDERWRITING AGREEMENTUnderwriting Agreement • November 12th, 2021 • AnPac Bio-Medical Science Co., Ltd. • Services-medical laboratories • New York
Contract Type FiledNovember 12th, 2021 Company Industry JurisdictionIt is understood that the several Underwriters are to make a public offering of the Public Shares as soon as the Representative deems it advisable to do so. The Public Shares are to be initially offered to the public at the public offering price set forth in the Prospectus Supplement. The Representative will take delivery of the Public Shares in the form of American Depositary Shares. The American Depositary Shares are to be issued pursuant to the Amended and Restated Deposit Agreement dated as of February 3, 2021 (the “Deposit Agreement”) among the Company, Citibank N.A. (the “Depositary”) and the owners and holders from time to time of the American Depositary Shares issued under the Deposit Agreement. Each American Depositary Share will represent the right to receive one Ordinary Share deposited pursuant to the Deposit Agreement. The Ordinary Shares of the Company represented by the ADSs may hereinafter be referred to as the “Underlying Securities.”
21,325,000 SHARES of Common Stock 23,437,500 COMMON WARRANTS (EXERCISABLE FOR 23,437,500 WARRANT SHARES) AND 2,112,500 PRE-FUNDED WARRANTS (EXERCISABLE FOR 2,112,500 WARRANT SHARES) TIMBER PHARMACEUTICALS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • November 4th, 2021 • Timber Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 4th, 2021 Company Industry JurisdictionThe undersigned, Timber Pharmaceuticals, Inc., a company incorporated under the laws of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of Timber Pharmaceuticals, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which H.C. Wainwright & Co., LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
3,483,120 SHARES OF COMMON STOCK OF NUWELLIS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • September 17th, 2021 • Nuwellis, Inc. • Electromedical & electrotherapeutic apparatus • New York
Contract Type FiledSeptember 17th, 2021 Company Industry JurisdictionThe undersigned, Nuwellis, Inc., a Delaware corporation (collectively with its subsidiaries, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries of Nuwellis, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters, if any (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”), named in Schedule I hereto for which Ladenburg Thalmann & Co. Inc. is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
METEN HOLDING GROUP LTD. UNDERWRITING AGREEMENTUnderwriting Agreement • September 7th, 2021 • Meten Holding Group Ltd. • Services-educational services • New York
Contract Type FiledSeptember 7th, 2021 Company Industry JurisdictionThe undersigned, Meten Holding Group Ltd, formerly known as Meten EdtechX Education Group Ltd., a Cayman Islands company limited by shares (collectively with its Subsidiaries (as defined below) the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Aegis Capital Corp. is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
UNDERWRITING AGREEMENTUnderwriting Agreement • August 31st, 2021 • Biotricity Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledAugust 31st, 2021 Company Industry JurisdictionThe undersigned, Biotricity Inc., a company incorporated under the laws of Nevada (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of Biotricity Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which H.C. Wainwright & Co., LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
UNDERWRITING AGREEMENTUnderwriting Agreement • July 19th, 2021 • Applied UV, Inc. • Electric lighting & wiring equipment • New York
Contract Type FiledJuly 19th, 2021 Company Industry JurisdictionThe undersigned, Applied UV, Inc., a company incorporated under the laws of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of Applied UV, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Ladenburg Thalmann & Co. Inc. is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
857,844 ORDINARY SHARES, NO PAR VALUE PER SHARE GREENLAND TECHNOLOGIES HOLDING CORPORATION UNDERWRITING AGREEMENTUnderwriting Agreement • June 30th, 2021 • Greenland Technologies Holding Corp. • General industrial machinery & equipment • New York
Contract Type FiledJune 30th, 2021 Company Industry JurisdictionThe undersigned, Greenland Technologies Holding Corporation, a British Virgin Islands company limited by shares (collectively with its Subsidiaries (as defined below) the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Aegis Capital Corp. is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
UNDERWRITING AGREEMENTUnderwriting Agreement • June 23rd, 2021 • Adial Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJune 23rd, 2021 Company Industry JurisdictionThe undersigned, Adial Pharmaceuticals, Inc., a company incorporated under the laws of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries of Adial Pharmaceuticals, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Oppenheimer & Co. Inc. is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
AMENDED AND RESTATED UNDERWRITING AGREEMENTUnderwriting Agreement • June 22nd, 2021 • Capstone Green Energy Corp • Engines & turbines • New York
Contract Type FiledJune 22nd, 2021 Company Industry JurisdictionThe undersigned, Capstone Green Energy Corporation, a company incorporated under the laws of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of Capstone Green Energy Corporation, the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which H.C. Wainwright & Co., LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein. This Amended and Restated Underwriting Agreement amends, restates, an
40,000,000 ORDINARY SHARES, PAR VALUE $0.0001 PER SHARE METEN EDTECHX EDUCATION GROUP LTD. UNDERWRITING AGREEMENTUnderwriting Agreement • May 26th, 2021 • Meten EdtechX Education Group Ltd. • Services-educational services • New York
Contract Type FiledMay 26th, 2021 Company Industry JurisdictionThe undersigned, Meten EdtechX Education Group Ltd., a Cayman Islands company limited by shares (collectively with its Subsidiaries (as defined below) the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Aegis Capital Corp. is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
UNDERWRITING AGREEMENTUnderwriting Agreement • May 4th, 2021 • Lianluo Smart LTD • Retail-retail stores, nec • New York
Contract Type FiledMay 4th, 2021 Company Industry JurisdictionThe undersigned, Lianluo Smart Limited (to be renamed Newegg Commerce, Inc.), a company incorporated under the laws of British Virgin Islands (collectively with its subsidiaries, the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Joint Book-Runners (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Maxim Group LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
FARMMI, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • May 3rd, 2021 • Farmmi, Inc. • Canned, fruits, veg, preserves, jams & jellies • New York
Contract Type FiledMay 3rd, 2021 Company Industry JurisdictionThe undersigned, Farmmi, Inc., a Cayman Islands company limited by shares (collectively with its Subsidiaries (as defined below) the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Aegis Capital Corp. is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
ANIXA BIOSCIENCES, INC. AMENDED AND RESTATED UNDERWRITING AGREEMENTUnderwriting Agreement • March 24th, 2021 • Anixa Biosciences Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 24th, 2021 Company Industry JurisdictionThe undersigned, Anixa Biosciences, Inc., a company incorporated under the laws of Delaware (collectively with its subsidiaries, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries of Anixa Biosciences, Inc. the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which H.C. Wainwright & Co., LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein. This Amended and Restated Underwriting Agreement amends, restates and supersedes in its entirety the prior underwriting
FARMMI, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • March 24th, 2021 • Farmmi, Inc. • Canned, fruits, veg, preserves, jams & jellies • New York
Contract Type FiledMarch 24th, 2021 Company Industry JurisdictionThe undersigned, Farmmi, Inc., a Cayman Islands company limited by shares (collectively with its Subsidiaries (as defined below) the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Aegis Capital Corp. is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
3,300,710 SHARES OF COMMON STOCK OF CHF SOLUTIONS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • March 17th, 2021 • CHF Solutions, Inc. • Electromedical & electrotherapeutic apparatus • New York
Contract Type FiledMarch 17th, 2021 Company Industry JurisdictionThe undersigned, CHF Solutions, Inc., a Delaware corporation (collectively with its subsidiaries, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries of CHF Solutions, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters, if any (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”), named in Schedule I hereto for which Ladenburg Thalmann & Co. Inc. is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
AMENDED AND RESTATED UNDERWRITING AGREEMENTUnderwriting Agreement • February 18th, 2021 • AIkido Pharma Inc. • Services-commercial physical & biological research • New York
Contract Type FiledFebruary 18th, 2021 Company Industry JurisdictionThe undersigned, H.C. Wainwright & Co., LLC (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of AIkido Pharma Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which H.C. Wainwright & Co., LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein. The Amended and Restated Underwriting Agreement amends, restates and supersedes in its entirety the prior underwriting dated as of February 16
UNDERWRITING AGREEMENTUnderwriting Agreement • February 17th, 2021 • Us Energy Corp • Crude petroleum & natural gas • New York
Contract Type FiledFebruary 17th, 2021 Company Industry JurisdictionThe undersigned, U.S. Energy Corp., a company incorporated under the laws of Wyoming (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of U.S. Energy Corp. (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Kingswood Capital Markets, a division of Benchmark Investments, Inc. is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
Zomedica Corp. AMENDED AND RESTATED UNDERWRITING AGREEMENTUnderwriting Agreement • February 9th, 2021 • Zomedica Corp. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 9th, 2021 Company Industry JurisdictionThe undersigned, Zomedica Corp., an Alberta corporation (the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which H.C. Wainwright & Co., LLC is acting as representative (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein. This Amended and Restated Underwriting Agreement amends, restates and supersedes in its entirety the prior underwriting agreement dated as of February 8, 2021, by and between the Company and the Representative.
5,190,000 SHARES OF COMMON STOCK OF PEDEVCO CORP. UNDERWRITING AGREEMENTUnderwriting Agreement • February 3rd, 2021 • Pedevco Corp • Crude petroleum & natural gas • New York
Contract Type FiledFebruary 3rd, 2021 Company Industry JurisdictionThe undersigned, PEDEVCO Corp., a company incorporated under the laws of Texas (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of PEDEVCO Corp., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Kingswood Capital Markets, division of Benchmark Investments, Inc., is acting as representative to the several Underwriters (in such capacity, the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriters) on the terms and conditions set forth herein.
YIELD10 BIOSCIENCE, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • February 2nd, 2021 • Yield10 Bioscience, Inc. • Miscellaneous plastics products • New York
Contract Type FiledFebruary 2nd, 2021 Company Industry JurisdictionYield10 Bioscience, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell an aggregate of 1,040,000 shares (“Firm Shares”, or “Securities”) of the Company’s common stock, $0.01 par value per share (“Shares”) to the several underwriters (such underwriters, for whom Maxim Group LLC (“Maxim” or the “Representative”) is acting as representative, the “Underwriters” and each an “Underwriter”). The offering of the Securities is hereinafter called the “Offering”.
2,434,783 AMERICAN DEPOSITARY SHARES EACH REPRESENTING 40 ORDINARY SHARES, NO PAR VALUE PER SHARE BIONDVAX PHARMACEUTICALS, LTD. UNDERWRITING AGREEMENTUnderwriting Agreement • February 2nd, 2021 • BiondVax Pharmaceuticals Ltd. • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 2nd, 2021 Company Industry JurisdictionThe undersigned, BiondVax Pharmaceuticals, Ltd., a company incorporated under the laws of Israel (collectively with its Subsidiaries (as defined below), if any, the “Company”), hereby confirms its agreement (this “Agreement”) with Aegis Capital Corp. (the “Underwriter”) on the terms and conditions set forth herein. The Underlying Ordinary Shares (as defined below) are to be deposited pursuant to a deposit agreement, as amended, dated May 11, 2015 (the “Deposit Agreement”), among the Company, The Bank of New York Mellon, as depositary (the “Depositary”), and holders and beneficial holders from time to time of the ADRs (as defined below) issued by the Depositary and evidencing the ADSs (as defined below). Each ADS represents 40 Ordinary Shares (as defined below) deposited pursuant to the Deposit Agreement.